Tumor-Killing ‘Cornell Dots’ Enter Their First Therapeutic Trial
Silica-encased fluorescent nanoparticles, otherwise known as “Cornell Dots”, have just entered their first therapeutic trial, following three successful diagnostic human clinical trials during which they proved their safety and effectiveness. These special nanoparticles were developed…